Eiger BioPharmaceuticals (Patent Right of Avexitide) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Eiger BioPharmaceuticals (Patent Right of Avexitide) General Information
Description
Patent rights for drug discovery based in Palo Alto, California.
Contact Information
Corporate Office
- Palo Alto, CA
- United States
Corporate Office
- Palo Alto, CA
- United States
Eiger BioPharmaceuticals (Patent Right of Avexitide) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Eiger BioPharmaceuticals (Patent Right of Avexitide) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Eiger BioPharmaceuticals (Patent Right of Avexitide) FAQs
-
Where is Eiger BioPharmaceuticals (Patent Right of Avexitide) headquartered?
Eiger BioPharmaceuticals (Patent Right of Avexitide) is headquartered in Palo Alto, CA.
-
What industry is Eiger BioPharmaceuticals (Patent Right of Avexitide) in?
Eiger BioPharmaceuticals (Patent Right of Avexitide)’s primary industry is Buildings and Property.
-
Is Eiger BioPharmaceuticals (Patent Right of Avexitide) a private or public company?
Eiger BioPharmaceuticals (Patent Right of Avexitide) is a Private company.
-
What is the current valuation of Eiger BioPharmaceuticals (Patent Right of Avexitide)?
The current valuation of Eiger BioPharmaceuticals (Patent Right of Avexitide) is .
-
What is Eiger BioPharmaceuticals (Patent Right of Avexitide)’s current revenue?
The current revenue for Eiger BioPharmaceuticals (Patent Right of Avexitide) is .
-
Who are Eiger BioPharmaceuticals (Patent Right of Avexitide)’s investors?
Eiger BioPharmaceuticals has invested in Eiger BioPharmaceuticals (Patent Right of Avexitide).
-
When was Eiger BioPharmaceuticals (Patent Right of Avexitide) acquired?
Eiger BioPharmaceuticals (Patent Right of Avexitide) was acquired on 09-Jul-2024.
-
Who acquired Eiger BioPharmaceuticals (Patent Right of Avexitide)?
Eiger BioPharmaceuticals (Patent Right of Avexitide) was acquired by Amylyx Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process